San Carlos, CA
SutroVax is a recently established biopharmaceutical company developing vaccines for infectious disease targets with an initial emphasis on best-in-class conjugate vaccines and protein-based vaccines.
sutrovax.comThese are collections SutroVax Inc. is a part of. Click on the collection name to view similar companies.
Post Ipo Equity
$1,500,000,000
Post Ipo Equity
$862,500,000
Post Ipo Equity
$500,000,000
Post Ipo Equity
$600,000,000
Post Ipo Equity
$100,000,000
Grant
$3,200,000
Grant
$2,700,000
Series D
$110,000,000
IPO
Unknown
Grant
$1,640,000
Series C
$85,000,000
Series B
$60,000,000
Series A
$22,000,000
0 out of 5 stars
Based on 0 reviews
Worked here? Share your experience. Help others decide if this company is right for them. Write a review on SutroVax Inc..